Nasal Polyposis Global Clinical Trials Review H2 2015


#354654

70pages

GlobalData

$ 2500

In Stock

Nasal Polyposis Global Clinical Trials Review H2 2015

Summary

GlobalDatas clinical trial report Nasal Polyposis Global Clinical Trials Review H2 2015" provides an overview of Nasal Polyposis clinical trials scenario. This report provides top line data relating to the clinical trials on Nasal Polyposis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region country (G7 & E7) phase trial status end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Datas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries conferences journals news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region Country (G7 & E7) Trial Status Trial Phase Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title Phase and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Nasal Polyposis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Nasal Polyposis to Ear Nose Throat Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Nasal Polyposis 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Nasal Polyposis Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Sanofi 27
Clinical Trial Overview of Sanofi 27
Regeneron Pharmaceuticals Inc. 28
Clinical Trial Overview of Regeneron Pharmaceuticals Inc. 28
Optinose US Inc. 29
Clinical Trial Overview of Optinose US Inc. 29
SC Clinical Research Inc 30
Clinical Trial Overview of SC Clinical Research Inc 30
PARI Medical Holding GmbH 31
Clinical Trial Overview of PARI Medical Holding GmbH 31
Optimed Research LTD. 32
Clinical Trial Overview of Optimed Research LTD. 32
Merck & Co. Inc. 33
Clinical Trial Overview of Merck & Co. Inc. 33
Intersect ENT Inc. 34
Clinical Trial Overview of Intersect ENT Inc. 34
GlaxoSmithKline Plc 35
Clinical Trial Overview of GlaxoSmithKline Plc 35
F. Hoffmann-La Roche Ltd. 36
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 36
Clinical Trial Overview of Top Institutes Government 37
Hamedan University of Medical Sciences 37
Clinical Trial Overview of Hamedan University of Medical Sciences 37
Massachusetts General Hospital 38
Clinical Trial Overview of Massachusetts General Hospital 38
Ghent University Hospital 39
Clinical Trial Overview of Ghent University Hospital 39
Isfahan University of Medical Sciences 40
Clinical Trial Overview of Isfahan University of Medical Sciences 40
Johannes Gutenberg University Mainz 41
Clinical Trial Overview of Johannes Gutenberg University Mainz 41
St. Elizabeths Medical Center 42
Clinical Trial Overview of St. Elizabeths Medical Center 42
University of Alberta 43
Clinical Trial Overview of University of Alberta 43
Five Key Clinical Profiles 44
Appendix 67
Abbreviations 67
Definitions 67
Research Methodology 68
Secondary Research 68
About GlobalData 69
Contact Us 69
Disclaimer 69
Source 70

List of Tables
Nasal Polyposis Therapeutics Global Clinical Trials by Region 2015* 7
Nasal Polyposis Therapeutics Global Clinical Trials and Average Enrollment by Top Countries 2015* 8
Nasal Polyposis Therapeutics Global Clinical Trials In Progress by Top Countries 2015* 9
Nasal Polyposis Therapeutics Clinical Trials Asia-Pacific Top Countries 2015* 10
Nasal Polyposis Therapeutics Clinical Trials Europe Top Five Countries 2015* 11
Nasal Polyposis Therapeutics Clinical Trials North America Top Countries 2015* 12
Nasal Polyposis Therapeutics Clinical Trials Middle East and Africa Top Countries 2015* 13
Proportion of Nasal Polyposis to Ear Nose Throat Disorders Clinical Trials G7 Countries (%) 2015* 14
Nasal Polyposis Therapeutics G7 Countries Clinical Trials by Phase 2015* 15
Nasal Polyposis Therapeutics G7 Countries Clinical Trials by Trial Status 2015* 16
Nasal Polyposis Therapeutics Global Clinical Trials by Phase 2015* 17
Nasal Polyposis Therapeutics Global Clinical Trials In Progress by Phase 2015* 18
Nasal Polyposis Therapeutics Global Clinical Trials by Trial Status 2015* 19
Nasal Polyposis Therapeutics Clinical Trials Global by End Point Status 2015* 20
Nasal Polyposis Therapeutics Global Terminated Clinical Trials 2015* 21
Nasal Polyposis Therapeutics Clinical Trials Global Average Enrollment Target Trends 2010-2014 22
Nasal Polyposis Therapeutics Market Global Clinical Trials by Sponsor Type 2015* 23
Nasal Polyposis Therapeutics Clinical Trials Global Key Sponsors 2015* 24
Nasal Polyposis Therapeutics Clinical Trials Global Top Companies by Phase 2015* 25
Nasal Polyposis Therapeutics Clinical Trials Global Ongoing Clinical Trials by Prominent Drugs 2015* 26
Nasal Polyposis Therapeutics Clinical Trials Market Global Clinical Trials by Sanofi 2015* 27
Nasal Polyposis Therapeutics Clinical Trials Market Global Clinical Trials by Regeneron Pharmaceuticals Inc. 2015* 28
Nasal Polyposis Therapeutics Clinical Trials Market Global Clinical Trials by Optinose US Inc. 2015* 29
Nasal Polyposis Therapeutics Clinical Trials Market Global Clinical Trials by SC Clinical Research Inc 2015* 30
Nasal Polyposis Therapeutics Clinical Trials Market Global Clinical Trials by PARI Medical Holding GmbH 2015* 31
Nasal Polyposis Therapeutics Clinical Trials Market Global Clinical Trials by Optimed Research LTD. 2015* 32
Nasal Polyposis Therapeutics Clinical Trials Market Global Clinical Trials by Merck & Co. Inc. 2015* 33
Nasal Polyposis Therapeutics Clinical Trials Market Global Clinical Trials by Intersect ENT Inc. 2015* 34
Nasal Polyposis Therapeutics Clinical Trials Market Global Clinical Trials by GlaxoSmithKline Plc 2015* 35
Nasal Polyposis Therapeutics Clinical Trials Market Global Clinical Trials by F. Hoffmann-La Roche Ltd. 2015* 36
Nasal Polyposis Therapeutics Clinical Trials Market Global Clinical Trials by Hamedan University of Medical Sciences 2015* 37
Nasal Polyposis Therapeutics Clinical Trials Market Global Clinical Trials by Massachusetts General Hospital 2015* 38
Nasal Polyposis Therapeutics Clinical Trials Market Global Clinical Trials by Ghent University Hospital 2015* 39
Nasal Polyposis Therapeutics Clinical Trials Market Global Clinical Trials by Isfahan University of Medical Sciences 2015* 40
Nasal Polyposis Therapeutics Clinical Trials Market Global Clinical Trials by Johannes Gutenberg University Mainz 2015* 41
Nasal Polyposis Therapeutics Clinical Trials Market Global Clinical Trials by St. Elizabeths Medical Center 2015* 42
Nasal Polyposis Therapeutics Clinical Trials Market Global Clinical Trials by University of Alberta 2015* 43

List of Figures
Nasal Polyposis Therapeutics Global Clinical Trials by Region (%) 2015* 7
Nasal Polyposis Therapeutics Global Clinical Trials and Average Enrollment by Top Countries 2015* 8
Nasal Polyposis Therapeutics Global Clinical Trials In Progress by Top Countries 2015* 9
Nasal Polyposis Therapeutics Clinical Trials Europe Top Five Countries (%) 2015* 11
Nasal Polyposis Therapeutics Clinical Trials North America Top Countries (%) 2015* 12
Nasal Polyposis Therapeutics Clinical Trials Middle East and Africa Top Countries (%) 2015* 13
Proportion of Nasal Polyposis to Ear Nose Throat Disorders Clinical Trials G7 Countries (%) 2015* 14
Nasal Polyposis Therapeutics G7 Countries Clinical Trials by Phase 2015* 15
Nasal Polyposis Therapeutics G7 Countries Clinical Trials by Trial Status 2015* 16
Nasal Polyposis Therapeutics Global Clinical Trials by Phase (%) 2015* 17
Nasal Polyposis Therapeutics Global Clinical Trials In Progress by Phase 2015* 18
Nasal Polyposis Therapeutics Global Clinical Trials by Trial Status 2015* 19
Nasal Polyposis Therapeutics Clinical Trials Global by End Point Status 2015* 20
Nasal Polyposis Therapeutics Clinical Trials Global Average Enrollment Target Trends 2010-2014 22
Nasal Polyposis Therapeutics Market Global Clinical Trials by Sponsor Type (%) 2015* 23
Nasal Polyposis Therapeutics Clinical Trials Global Key Sponsors 2015* 24
Nasal Polyposis Therapeutics Clinical Trials Global Top Companies by Phase 2015* 25
Nasal Polyposis Therapeutics Clinical Trials Global Ongoing Clinical Trials by Prominent Drugs 2015* 26
GlobalData Methodology 68